Bruno Horisberger

1.4k total citations
36 papers, 955 citations indexed

About

Bruno Horisberger is a scholar working on Economics and Econometrics, General Health Professions and Pharmacology. According to data from OpenAlex, Bruno Horisberger has authored 36 papers receiving a total of 955 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Economics and Econometrics, 7 papers in General Health Professions and 6 papers in Pharmacology. Recurrent topics in Bruno Horisberger's work include Health Systems, Economic Evaluations, Quality of Life (9 papers), Musculoskeletal pain and rehabilitation (6 papers) and Acute Lymphoblastic Leukemia research (4 papers). Bruno Horisberger is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (9 papers), Musculoskeletal pain and rehabilitation (6 papers) and Acute Lymphoblastic Leukemia research (4 papers). Bruno Horisberger collaborates with scholars based in Switzerland, Spain and Sweden. Bruno Horisberger's co-authors include Aloïs Gratwohl, Helen Baldomero, Álvaro Urbano-Ispizúa, Achim Elfering, Anne F. Mannion, Claudia Eisenring, Özgür Tamcan, Jakob Passweg, Urs Müller and C. Schmid and has published in prestigious journals such as Blood, Circulation Research and Pain.

In The Last Decade

Bruno Horisberger

34 papers receiving 897 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruno Horisberger Switzerland 14 269 254 245 152 138 36 955
Jörg Ruof Germany 21 188 0.7× 112 0.4× 401 1.6× 78 0.5× 160 1.2× 67 1.4k
Marieke Voshaar Netherlands 20 634 2.4× 87 0.3× 136 0.6× 122 0.8× 225 1.6× 46 2.1k
Julie Krop United States 13 174 0.6× 69 0.3× 75 0.3× 98 0.6× 103 0.7× 33 1.2k
Sonja Merkesdal Germany 18 185 0.7× 96 0.4× 173 0.7× 34 0.2× 141 1.0× 46 1.1k
Barry E. Koehler Canada 11 74 0.3× 249 1.0× 107 0.4× 47 0.3× 69 0.5× 20 1.6k
David Phillippo United Kingdom 16 103 0.4× 72 0.3× 221 0.9× 81 0.5× 47 0.3× 29 1.1k
Julie Birt United States 22 260 1.0× 76 0.3× 226 0.9× 82 0.5× 83 0.6× 61 1.2k
Mary M. Hunter United States 6 96 0.4× 70 0.3× 192 0.8× 63 0.4× 99 0.7× 14 771
Jiat Ling Poon United States 19 294 1.1× 97 0.4× 109 0.4× 41 0.3× 67 0.5× 73 974
Amye Leong United States 17 206 0.8× 53 0.2× 69 0.3× 60 0.4× 203 1.5× 34 799

Countries citing papers authored by Bruno Horisberger

Since Specialization
Citations

This map shows the geographic impact of Bruno Horisberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Horisberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Horisberger more than expected).

Fields of papers citing papers by Bruno Horisberger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruno Horisberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Horisberger. The network helps show where Bruno Horisberger may publish in the future.

Co-authorship network of co-authors of Bruno Horisberger

This figure shows the co-authorship network connecting the top 25 collaborators of Bruno Horisberger. A scholar is included among the top collaborators of Bruno Horisberger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruno Horisberger. Bruno Horisberger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brügger, Urs, Andreas Ruckstuhl, Bruno Horisberger, & Aloïs Gratwohl. (2014). DEVELOPMENT OF COVERAGE WITH EVIDENCE DEVELOPMENT FOR MEDICAL TECHNOLOGIES IN SWITZERLAND FROM 1996 TO 2012. International Journal of Technology Assessment in Health Care. 30(3). 253–259. 5 indexed citations
2.
Wieser, Simon, et al.. (2011). Cost of low back pain in Switzerland in 2005 Simon WieserBruno HorisbergerSara SchmidhauserClaudia Eisenring • Urs BruggerAndreas RuckstuhlJurg DietrichAnne F. Mannion •. 9 indexed citations
3.
Wieser, Simon, Bruno Horisberger, Claudia Eisenring, et al.. (2010). Cost of low back pain in Switzerland in 2005. The European Journal of Health Economics. 12(5). 455–467. 155 indexed citations
4.
Tamcan, Özgür, Anne F. Mannion, Claudia Eisenring, et al.. (2010). The course of chronic and recurrent low back pain in the general population. Pain. 150(3). 451–457. 92 indexed citations
5.
Mannion, Anne F., Bruno Horisberger, Claudia Eisenring, et al.. (2009). The Association Between Beliefs About Low Back Pain and Work Presenteeism. Journal of Occupational and Environmental Medicine. 51(11). 1256–1266. 41 indexed citations
6.
Gratwohl, Aloïs, et al.. (2005). Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: a report of the EBMT activity survey 2003. Bone Marrow Transplantation. 36(7). 575–590. 79 indexed citations
7.
Gratwohl, Aloïs, et al.. (2004). Haematopoietic stem cell transplantation (HSCT) in Europe 2002. Changes in indication and impact of team density. A report of the EBMT activity survey. Bone Marrow Transplantation. 34(10). 855–875. 40 indexed citations
8.
Gratwohl, Aloïs, Jakob Passweg, Helen Baldomero, Bruno Horisberger, & Álvaro Urbano-Ispizúa. (2002). Economics, health care systems and utilization of haematopoietic stem cell transplants in Europe. British Journal of Haematology. 117(2). 451–468. 48 indexed citations
9.
Gessner, U., et al.. (2000). Economic analysis of terminal care for patients with malignant osteolytic bone disease and pain treated with pamidronate. Supportive Care in Cancer. 8(2). 115–122. 17 indexed citations
10.
Brandt-Casadevall, C., et al.. (2000). The challenge of identification following the tragedy of the Solar Temple (Cheiry/Salvan, Switzerland). Forensic Science International. 110(3). 215–226. 5 indexed citations
11.
Drummond, Michael, Dominique Dubois, Livio Garattini, et al.. (1999). Current Trends in the Use of Pharmacoeconomics and Outcomes Research in Europe. Value in Health. 2(5). 323–332. 51 indexed citations
12.
Sagmeister, Markus, et al.. (1997). An economic analysis of ischaemic heart disease in Switzerland. European Heart Journal. 18(7). 1102–1109. 22 indexed citations
13.
Culyer, Anthony J., Bruno Horisberger, B. Jönsson, & Frans Rutten. (1993). Introduction. European Journal of Cancer. 29. S1–S2.
14.
Drummond, Michael, Frans Rutten, Bruno Horisberger, et al.. (1993). Economic Evaluation of Pharmaceuticals. PharmacoEconomics. 4(3). 173–186. 70 indexed citations
15.
Horisberger, Bruno, et al.. (1991). Improving Drug Safety — A Joint Responsibility. 8 indexed citations
16.
Jönsson, Bengt, Bruno Horisberger, Miguel Bruguera, & L Matter. (1991). Cost-Benefit Analysis of Hepatitis-B Vaccination: A Computerized Decision Model for Spain. International Journal of Technology Assessment in Health Care. 7(3). 379–402. 31 indexed citations
17.
Horisberger, Bruno, et al.. (1991). Socioeconomic Aspects of an Implantable Drug Delivery Device. Recent results in cancer research. 121. 223–232. 1 indexed citations
18.
Sagmeister, Markus, Bruno Horisberger, & U. Gessner. (1990). The costs of ischaemic heart disease in Switzerland. Zurich Open Repository and Archive (University of Zurich). 1(1). 5–16. 4 indexed citations
19.
Horisberger, Bruno & Simon Rodbard. (1961). Relation between pain and fatigue in contracting ischemic muscle. The American Journal of Cardiology. 8(4). 481–484. 3 indexed citations
20.
Horisberger, Bruno & Simon Rodbard. (1960). Direct Measurement of Bronchial Arterial Flow. Circulation Research. 8(6). 1149–1156. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026